Cargando…
Chemotherapeutic Nanoparticle-Based Liposomes Enhance the Efficiency of Mild Microwave Ablation in Hepatocellular Carcinoma Therapy
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer, and the 5-year overall survival (OS) rate for HCC remains unsatisfying worldwide. Microwave ablation (MWA) is a minimally invasive therapy that has made progress in treating HCC. However, HCC recurrence remains problemat...
Autores principales: | Wu, Songsong, Zhang, Dongyun, Yu, Jie, Dou, Jianping, Li, Xin, Mu, Mengjuan, Liang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054279/ https://www.ncbi.nlm.nih.gov/pubmed/32174827 http://dx.doi.org/10.3389/fphar.2020.00085 |
Ejemplares similares
-
Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression
por: Cui, Rui, et al.
Publicado: (2022) -
Perfluoropentane/apatinib-encapsulated metal–organic framework nanoparticles enhanced the microwave ablation of hepatocellular carcinoma
por: Zhang, Dongyun, et al.
Publicado: (2023) -
Prognostic Significance of Advanced Age in Patients with T1a Renal Cell Carcinoma Treated by Microwave Ablation: A 16-Year Experience
por: Hou, Qidi, et al.
Publicado: (2023) -
Suppression of CD13 Enhances the Cytotoxic Effect of Chemotherapeutic Drugs in Hepatocellular Carcinoma Cells
por: Ji, Shengping, et al.
Publicado: (2021) -
A Machine Learning Model Based on Health Records for Predicting Recurrence After Microwave Ablation of Hepatocellular Carcinoma
por: An, Chao, et al.
Publicado: (2022)